Cargando…
Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older
BACKGROUND: To examine the role of brachytherapy for aged patients 80 or more in the trend of rapidly increasing number. METHODS: We examined the outcomes for elderly patients with node negative oral tongue cancer (T1-3N0M0) treated with brachytherapy. The 21 patients (2 T1, 14 T2, and 5 T3 cases) r...
Autores principales: | Yamazaki, Hideya, Yoshida, Ken, Kotsuma, Tadayuki, Yoshioka, Yasuo, Koizumi, Masahiko, Furukawa, Souhei, Kakimoto, Naoya, Shimizutani, Kimishige, Nishimura, Tsunehiko |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016284/ https://www.ncbi.nlm.nih.gov/pubmed/21143904 http://dx.doi.org/10.1186/1748-717X-5-116 |
Ejemplares similares
-
Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer
por: Akiyama, Hironori, et al.
Publicado: (2012) -
High dose rate brachytherapy for oral cancer
por: YamazakI, Hideya, et al.
Publicado: (2013) -
High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial
por: Akiyama, Hironori, et al.
Publicado: (2014) -
Edema worsens target coverage in high-dose-rate interstitial brachytherapy of mobile tongue cancer: a report of two cases
por: Yoshida, Ken, et al.
Publicado: (2017) -
Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer
por: Yoshida, Ken, et al.
Publicado: (2014)